SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-16-780885
Filing Date
2016-11-30
Accepted
2016-11-30 16:05:56
Documents
5
Period of Report
2016-11-30

Document Format Files

Seq Description Document Type Size
1 6-K d299162d6k.htm 6-K 10333
2 UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS d299162dex991.htm EX-99.1 180327
3 MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION RESULTS OF OPERATION d299162dex992.htm EX-99.2 88864
4 PRESS RELEASE DATED NOVEMBER 30, 2016 d299162dex993.htm EX-99.3 66830
5 GRAPHIC g299162ex993logo.jpg GRAPHIC 10973
  Complete submission text file 0001193125-16-780885.txt   362593
Mailing Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900 45 36 94 44 86
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 162025370
SIC: 2834 Pharmaceutical Preparations